Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 26-Week, Open-Label, Randomized, Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin In Subjects With Type-1 Diabetes Mellitus

NCT00668850 is registered in ClinicalTrials.gov with Generex Biotechnology Corp. as lead sponsor.

NCT NCT00668850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00668850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 26-Week, Open-Label, Randomized, Active Comparator Study of Generex Oral-lyn™ Spray and Injected Human Insulin In Subjects With Type-1 Diabetes Mellitus
Lead sponsor
Generex Biotechnology Corp.
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2008
Completion date
September 30, 2011
Enrollment
500 (estimated)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus